1. Home
  2. PCYO vs AVXL Comparison

PCYO vs AVXL Comparison

Compare PCYO & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pure Cycle Corporation

PCYO

Pure Cycle Corporation

N/A

Current Price

$10.43

Market Cap

242.8M

Sector

Utilities

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.01

Market Cap

251.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCYO
AVXL
Founded
1976
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.8M
251.1M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
PCYO
AVXL
Price
$10.43
$3.01
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$22.00
AVG Volume (30 Days)
50.2K
943.0K
Earning Date
04-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
12.50
N/A
EPS
0.23
N/A
Revenue
$1,227,787.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$46.35
N/A
Revenue Growth
171.54
N/A
52 Week Low
$9.65
$2.61
52 Week High
$12.44
$13.99

Technical Indicators

Market Signals
Indicator
PCYO
AVXL
Relative Strength Index (RSI) 43.68 48.02
Support Level $9.85 $2.93
Resistance Level $10.97 $3.50
Average True Range (ATR) 0.46 0.17
MACD -0.05 0.02
Stochastic Oscillator 25.28 51.03

Price Performance

Historical Comparison
PCYO
AVXL

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: